Breast cancer in young women and prognosis: How important are proliferation markers?
Hanna Fredholm(Karolinska University Hospital), Irma Fredriksson(Karolinska University Hospital), Fredrik Pontén(Uppsala University), Nicholas P. Tobin(Karolinska University Hospital), Jan Frisell(Karolinska University Hospital), Henrik Lindman(Uppsala University), Jonas Bergh(Karolinska Institutet), Lars Holmberg(Uppsala University), Kristina Magnusson(Uppsala University), Linda S. Lindström(Uppsala University)
Cited by 86
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k